Stock TRDA ENTRADA THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Entrada Therapeutics, Inc.

Equities

TRDA

US29384C1080

Real-time Estimate Cboe BZX
Other stock markets
 02:14:39 2024-05-23 pm EDT 		5-day change 1st Jan Change
15.42 USD -3.65% Intraday chart for Entrada Therapeutics, Inc. +5.02% +4.04%
May. 20 Entrada Therapeutics Insider Sold Shares Worth $287,695, According to a Recent SEC Filing MT
May. 16 Entrada Therapeutics Insider Bought Shares Worth $364,673, According to a Recent SEC Filing MT
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
ENTRADA THERAPEUTICS, INC. Stock Entrada Therapeutics, Inc.
 508M -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 115B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 106B
BIONTECH SE Stock BioNTech SE
 24.69B -
ARGENX SE Stock argenx SE
 21.97B -
GENMAB A/S Stock Genmab A/S
 19.27B
  1. Stock Market
  2. Equities
  3. TRDA Stock
  4. Charts Entrada Therapeutics, Inc.
  5. Sector Chart